<?xml version="1.0" encoding="UTF-8"?>
<HtmlDoc>
    <meta>
        <prop name="uid">https://www.ncbi.nlm.nih.gov/pubmed/28811946?report=xml&amp;format=text</prop>
        <prop name="date">2017-09-29</prop>
        <prop name="copyright">Converted by Semantic Hub (c) 2016</prop>
        <prop name="version">1.0</prop>
        <prop name="query">(potent AND inhibitor AND cancer) : 2015-2017</prop>
    </meta>
    <BODY>
        <ITEM>
            <ITEM_LINK>https://www.ncbi.nlm.nih.gov/pubmed/28811946?report=xml&amp;format=text</ITEM_LINK>
            <ITEM_BODY>
                <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
                    <PMID Version="1">28811946</PMID>
                    <DateCreated>
                        <Year>2017</Year>
                        <Month>08</Month>
                        <Day>16</Day>
                    </DateCreated>
                    <DateRevised>
                        <Year>2017</Year>
                        <Month>08</Month>
                        <Day>18</Day>
                    </DateRevised>
                    <Article PubModel="Print-Electronic">
                        <Journal>
                            <ISSN IssnType="Print">2090-6706</ISSN>
                            <JournalIssue CitedMedium="Print">
                                <Volume>2017</Volume>
                                <PubDate>
                                    <Year>2017</Year>
                                </PubDate>
                            </JournalIssue>
                            <Title>Case reports in oncological medicine</Title>
                            <ISOAbbreviation>Case Rep Oncol Med</ISOAbbreviation>
                        </Journal>
                        <ArticleTitle>
                            Are All Mutations the Same? A Rare Case Report of Coexisting Mutually Exclusive KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma.
                        </ArticleTitle>
                        <Pagination>
                            <MedlinePgn>2321052</MedlinePgn>
                        </Pagination>
                        <ELocationID ValidYN="Y" EIdType="doi">10.1155/2017/2321052</ELocationID>
                        <Abstract>
                            <AbstractText>
                                29-year-old Hispanic woman presented to the clinic with complaints of abdominal pain, nausea, fatigue, and constipation. Laboratory tests indicated the presence of iron deficiency anemia and transaminitis. Imaging evaluation revealed marked hepatomegaly with multiple hepatic metastases and pelvic lymphadenopathy. Biopsy of the hepatic lesions showed adenocarcinoma positive for pan-cytokeratin, CMA5.2, villin, and CDX2. She was positive for tumor markers CA 19-9, CA-125, and CEA. Upon further evaluation, she was found to have colorectal cancer positive for KRAS and BRAF mutations. Unfortunately, her disease progressed rapidly and she expired within 3 months from the time of her first diagnosis. KRAS and BRAF mutations are rare enough to be considered virtually mutually exclusive but coexistent mutations appear to be a distinct molecular and clinical subset with aggressive course of illness, which is in dire need of new treatment strategies. Panitumumab and Cetuximab are approved for patients with wild type KRAS CRC. Vemurafenib is a potent inhibitor of the kinase domain in mutant BRAF and its use in BRAF mutated colon cancer remains to be well established. Our report highlights the need to obtain tissue samples from these patients for analysis and to evaluate the benefit of Vemurafenib in colorectal cancers.
                            </AbstractText>
                        </Abstract>
                        <AuthorList CompleteYN="Y">
                            <Author ValidYN="Y">
                                <LastName>Vittal</LastName>
                                <ForeName>Anusha</ForeName>
                                <Initials>A</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Middinti</LastName>
                                <ForeName>Akshay</ForeName>
                                <Initials>A</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Kasi Loknath Kumar</LastName>
                                <ForeName>Anup</ForeName>
                                <Initials>A</Initials>
                                <Identifier Source="ORCID">0000-0002-4305-5701</Identifier>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Division of Medical Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                        </AuthorList>
                        <Language>eng</Language>
                        <PublicationTypeList>
                            <PublicationType UI="D016428">Journal Article</PublicationType>
                        </PublicationTypeList>
                        <ArticleDate DateType="Electronic">
                            <Year>2017</Year>
                            <Month>07</Month>
                            <Day>24</Day>
                        </ArticleDate>
                    </Article>
                    <MedlineJournalInfo>
                        <Country>United States</Country>
                        <MedlineTA>Case Rep Oncol Med</MedlineTA>
                        <NlmUniqueID>101581035</NlmUniqueID>
                    </MedlineJournalInfo>
                    <CommentsCorrectionsList>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Clin Oncol. 2015 Mar 1;33(7):692-700</RefSource>
                            <PMID Version="1">25605843</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Ann Surg Oncol. 2010 May;17 (5):1429-34</RefSource>
                            <PMID Version="1">20049644</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Res. 2006 Apr 15;66(8):3992-5</RefSource>
                            <PMID Version="1">16618717</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Gut. 2009 Sep;58(9):1234-41</RefSource>
                            <PMID Version="1">19474002</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cell. 2004 Mar 19;116(6):855-67</RefSource>
                            <PMID Version="1">15035987</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Lancet. 2011 Jun 18;377(9783):2103-14</RefSource>
                            <PMID Version="1">21641636</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>N Engl J Med. 2013 Sep 12;369(11):1023-34</RefSource>
                            <PMID Version="1">24024839</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Eur J Cancer. 2015 Sep;51(13):1704-13</RefSource>
                            <PMID Version="1">26049686</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Ann Oncol. 2014 Jul;25(7):1346-55</RefSource>
                            <PMID Version="1">24718886</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Biol Ther. 2014 Jul;15(7):826-31</RefSource>
                            <PMID Version="1">24755613</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</RefSource>
                            <PMID Version="1">26742998</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Cancer. 2013;4(4):320-2</RefSource>
                            <PMID Version="1">23569465</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Clin Oncol. 2014 Jul 20;32(21):2240-7</RefSource>
                            <PMID Version="1">24687833</PMID>
                        </CommentsCorrections>
                    </CommentsCorrectionsList>
                </MedlineCitation>
                <PubmedData>
                    <History>
                        <PubMedPubDate PubStatus="received">
                            <Year>2017</Year>
                            <Month>03</Month>
                            <Day>13</Day>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="revised">
                            <Year>2017</Year>
                            <Month>06</Month>
                            <Day>05</Day>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="accepted">
                            <Year>2017</Year>
                            <Month>06</Month>
                            <Day>15</Day>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="entrez">
                            <Year>2017</Year>
                            <Month>8</Month>
                            <Day>17</Day>
                            <Hour>6</Hour>
                            <Minute>0</Minute>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="pubmed">
                            <Year>2017</Year>
                            <Month>8</Month>
                            <Day>16</Day>
                            <Hour>6</Hour>
                            <Minute>0</Minute>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="medline">
                            <Year>2017</Year>
                            <Month>8</Month>
                            <Day>16</Day>
                            <Hour>6</Hour>
                            <Minute>1</Minute>
                        </PubMedPubDate>
                    </History>
                    <PublicationStatus>ppublish</PublicationStatus>
                    <ArticleIdList>
                        <ArticleId IdType="pubmed">28811946</ArticleId>
                        <ArticleId IdType="doi">10.1155/2017/2321052</ArticleId>
                        <ArticleId IdType="pmc">PMC5546060</ArticleId>
                    </ArticleIdList>
                </PubmedData>
            </ITEM_BODY>
        </ITEM>
    </BODY>
</HtmlDoc>